Citations (7)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Divakar Selvaraj, Santhoshkumar Muthu, Satvik Kotha, Ramachandra Setty Siddamsetty, Sasikumar Andavar & Saravanan Jayaraman. (2021) Syringaresinol as a novel androgen receptor antagonist against wild and mutant androgen receptors for the treatment of castration-resistant prostate cancer: molecular docking, in-vitro and molecular dynamics study. Journal of Biomolecular Structure and Dynamics 39:2, pages 621-634.
Read now
Read now
Hiten RH Patel. (2014) Foreword. Expert Review of Anticancer Therapy 14:11, pages 1251-1252.
Read now
Read now
Articles from other publishers (5)
Emma Scott & Jennifer Munkley. (2019) Glycans as Biomarkers in Prostate Cancer. International Journal of Molecular Sciences 20:6, pages 1389.
Crossref
Crossref
Robert Lang, Andreas Leinenbach, Johann Karl, Magdalena Swiatek-de Lange, Uwe Kobold & Michael Vogeser. (2018) An endoglycosidase-assisted LC-MS/MS-based strategy for the analysis of site-specific core-fucosylation of low-concentrated glycoproteins in human serum using prostate-specific antigen (PSA) as example. Clinica Chimica Acta 480, pages 1-8.
Crossref
Crossref
Kirsten R. Carlaw & Henry H. Woo. (2017) Evaluation of the changing landscape of prostate cancer diagnosis and management from 2005 to 2016. Prostate International 5:4, pages 130-134.
Crossref
Crossref
Jiaqi Wang, Huamao Ye, Dandan Zhang, Yijun Hu, Xiya Yu, Long Wang, Changjing Zuo, Yongwei Yu, Guixia Xu & Shanrong Liu. (2016) MicroRNA-410-5p as a potential serum biomarker for the diagnosis of prostate cancer. Cancer Cell International 16:1.
Crossref
Crossref
Petros Sountoulides. (2016) Active Surveillance for Low-Risk Prostate Cancer; A Plea for Increased Urologist Awareness. Urology & Nephrology Open Access Journal 3:1.
Crossref
Crossref